Literature DB >> 8389063

The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes.

C Léculier1, N Couprie, P Adeleine, P Leitienne, A Francina, M Richard.   

Abstract

High molecular weight (HMW) and low molecular weight (LMW) heparins affected superoxide ion production and degranulation by polymorphonuclear leukocytes (PMNL) isolated from either chronic hemodialyzed patients or healthy controls. Low concentrations in HMW-heparin, below 1.76 aXa IU/ml for patients and 1.34 aXa IU/ml for controls, increased O2- production started by phorbol myristate acetate. High concentrations above these values decreased it. Increasing LMW-heparin concentrations constantly decreased O2- production using the same stimulus. Myeloperoxidase (MPO) released by PMNL was found to be significantly HMW- and LMW-heparins dose-dependent. The addition of calcium chloride significantly increased MPO release. Lactoferrin release was not dose-dependent of HMW- or LMW-heparins. However, an increase of the percentage of positive responses for lactoferrin release was observed in the simultaneous presence of HMW-heparin and CaCl2 compared to HMW-heparin alone. Lysozyme release was also not dose-dependent of HMW- or LMW-heparins. An increase of the percentage of positive responses for lysozyme release was observed in the presence of CaCl2 alone compared to HMW-heparin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389063     DOI: 10.1016/0049-3848(93)90056-t

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

Review 1.  Myeloperoxidase production by macrophage and risk of atherosclerosis.

Authors:  Mahir Karakas; Wolfgang Koenig
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

Review 3.  Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?

Authors:  I García-Escobar; C Beato-Zambrano; J Muñoz Langa; E Brozos Vázquez; B Obispo Portero; D Gutiérrez-Abad; A J Muñoz Martín
Journal:  Clin Transl Oncol       Date:  2018-02-22       Impact factor: 3.405

Review 4.  Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease.

Authors:  Nisha Panth; Keshav Raj Paudel; Kalpana Parajuli
Journal:  Adv Med       Date:  2016-09-28

Review 5.  The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.

Authors:  Nathaniel Teng; Ghassan J Maghzal; Jihan Talib; Imran Rashid; Antony K Lau; Roland Stocker
Journal:  Redox Rep       Date:  2016-11-25       Impact factor: 4.412

6.  Ex vivo observation of granulocyte activity during thrombus formation.

Authors:  Daria S Morozova; Alexey A Martyanov; Sergei I Obydennyi; Julia-Jessica D Korobkin; Alexey V Sokolov; Ekaterina V Shamova; Irina V Gorudko; Anna L Khoreva; Anna Shcherbina; Mikhail A Panteleev; Anastasia N Sveshnikova
Journal:  BMC Biol       Date:  2022-02-07       Impact factor: 7.431

7.  Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients.

Authors:  Louise Schilder; S Azam Nurmohamed; Pieter M ter Wee; Nanne J Paauw; Armand R J Girbes; Albertus Beishuizen; Robert H J Beelen; A B Johan Groeneveld
Journal:  BMC Nephrol       Date:  2014-01-17       Impact factor: 2.388

8.  Heparin Interaction with the Primed Polymorphonuclear Leukocyte CD11b Induces Apoptosis and Prevents Cell Activation.

Authors:  Meital Cohen-Mazor; Rafi Mazor; Batya Kristal; Erik B Kistler; Inbal Ziv; Judith Chezar; Shifra Sela
Journal:  J Immunol Res       Date:  2015-12-27       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.